entity

CIN

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5Connections

30Hypotheses

0Analyses

5Outgoing

0Incoming

11Experiments

0Debates

No AI portrait yet

Wiki Pages (1)

Knowledge base pages for this entity

CING1 Gene

gene · 2374 words

→

Outgoing (5)

Target	Relation	Type	Str
AGING	associated_with	phenotype	0.72
PROGEROID_PHENOTYPES	associated_with	phenotype	0.72
NEURODEGENERATION	causes	disease	0.64
CELLULAR_SENESCENCE	regulates	phenotype	0.64
NEURONAL_CELL_DEATH	contributes_to	phenotype	0.56

Incoming (0)

Source	Relation	Type	Str
No incoming edges

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Sleep-Dependent Glymphatic Clearance Expands the Therapeutic	0.780	neurodegeneration	What is the therapeutic window between t
Enhancing Microglial Phagocytosis of Extracellular Tau via T	0.752	neuroscience	Trans-synaptic tau spreading and propaga
Selective LXRβ agonists restore ABCA1/ABCG1 expression and A	0.728	neuroscience	APOE4-driven lipid metabolism dysregulat
Spatiotemporal coupling between TRPML1-mediated lysosomal ca	0.705	neurodegeneration	What determines the specificity of calci
SCFA-Producing Bacterial Depletion → Loss of Neuroprotective	0.700	neurodegeneration	What are the mechanisms by which gut mic

Ganglioside Rebalancing Therapy	0.690	neurodegeneration	Lipid raft composition changes in synapt
Astrocyte-Selective APOE4 Silencing via Lipid Nanoparticles	0.682	neurodegeneration	Which cell types show the most significa
Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A	0.669	neurodegeneration	What are the mechanisms by which gut mic
H6: miR-132/212 Cluster Silencing Disables Neuronal Chromati	0.660	neurodegeneration	Investigate mechanisms of epigenetic rep
Astrocyte-Microglia Communication Rebalancing via Cytokine M	0.655	neurodegeneration	Which cell types show the most significa
mTORC1 displacement from lysosomal surface enables calcineur	0.650	neurodegeneration	What determines the specificity of calci
IL-10-Producing B10 Cells Establish AQP4-Specific Peripheral	0.648	neuroinflammation	How do B cells mechanistically orchestra
Epigenetic Silencing of AIF1 Gene Locus by Chronic Inflammat	0.643	neuroinflammation	What causes IBA1 low/negative microglia
HDAC2 Phospho-Lock Window for Synaptic Gene Silencing	0.643	neurodegeneration	What is the optimal therapeutic window d
Glycine-Rich Domain Competitive Inhibition	0.640	neurodegeneration	TDP-43 phase separation therapeutics for
HBOT at 1.5 ATA for 60 min induces hormetic response via Nrf	0.640	neurodegeneration	What are the optimal oxygen pressure, du
Butyrate-Producing Commensal Depletion Creates Vicious Cycle	0.630	neurodegeneration	How does gut microbiome dysbiosis contri
TREM2 Antagonism in Late-Stage Tauopathy — Reducing Neuroinf	0.628	Alzheimer's disease	TREM2 agonism vs antagonism in DAM micro
Nuclear TDP-43 Depletion Drives Synaptic Splicing Dysregulat	0.620	neurodegeneration	Gap 006 analysis (archived stub)
Calmodulin isoform switching from CaMK to calcineurin activa	0.607	neurodegeneration	What determines the specificity of calci
Enteric Nervous System Dysfunction as Self-Reinforcing Patho	0.605	neurodegeneration	Gut-Brain Axis in Parkinson's Disease: M
PIKFYVE Inhibition Activates Aggregate Exocytosis via PI(3,5	0.584	neurodegeneration	How does PIKFYVE inhibition activate unc
APOE4 drives astrocyte metabolic reprogramming toward glycol	0.580	neuroscience	APOE4-driven lipid metabolism dysregulat
Structure-interacting small molecules that stabilize the APO	0.580	neuroscience	APOE4-driven lipid metabolism dysregulat
TREM2 Promoter Silencing via DNA Hypermethylation	0.576	developmental neurobiology	Do perinatal immune challenges create pe
5-HT2A/C Silencing Enables Sustained BDNF-TrkB Signaling for	0.545	-	What is the minimum effective dose of tr
Cryptic Exon Silencing Restoration	0.531	neurodegeneration	RNA binding protein dysregulation across
REST-like neuronal silencing programs suppress MAPT in sever	0.506	neurodegeneration	Which specific transcription factors med
HBOT at 1.5 ATA for 90 days restores BBB integrity by upregu	0.460	neurodegeneration	What are the optimal oxygen pressure, du
Enhancing Heparan Sulfate 3-O-Sulfotransferase Activity to C	0.000	neuroscience	Trans-synaptic tau spreading and propaga

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (11)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Electroacupuncture ST37 treatment for DSS-induced colitis in mice	validation	colitis	0.950	0.00	mice	proposed	N/A
HFD-induced cognitive dysfunction and neuroinflammation in mice	validation	diet-induced cognitive dysfunc	0.900	0.00	adult Swiss male mice	proposed	N/A
LPS-induced mouse model of depression with synaptic loss analysis	validation	depression	0.900	0.00	LPS-treated mice	proposed	N/A
Network pharmacology analysis of QTJD active compounds and pathways	exploratory	Mycoplasma pneumoniae pneumoni	0.900	0.00	computational network analysis	proposed	N/A
Bidirectional Mendelian randomization analysis of C1Q and ischemic str	exploratory	Ischemic stroke, Atheroscleros	0.900	0.00	Human genetic association data	proposed	N/A
Bidirectional Mendelian randomization analysis of C1Q and ischemic str	exploratory	Ischemic stroke (large artery	0.900	0.00	human genetic data	proposed	N/A
Multi-omics analysis of myricanol effects on gene expression and micro	exploratory	hyperlipidemia	0.880	0.00	C57BL/6J mouse liver and epidi	proposed	N/A
α7nAChR agonist treatment rescues HFD-induced memory deficits	validation	diet-induced cognitive dysfunc	0.850	0.00	HFD-fed adult Swiss male mice	proposed	N/A
C1q neutralizing antibody intervention in depression model	validation	depression	0.850	0.00	LPS-treated mice with C1q anti	proposed	N/A
α7nAChR knockout mice show enhanced HFD sensitivity	validation	diet-induced cognitive dysfunc	0.800	0.00	Chrna7 knockout mice	proposed	N/A
Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$7,100,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegenerat [PMID:37995685]	Litvinchuk A, Suh JH, Guo JL, Lin K, Dav	Neuron	2024	1
The cell biology of APOE in the brain. [PMID:37805344]	Windham IA, Cohen S	Trends Cell Biol	2024	1
APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia. [PMID:33658354]	Sienski G, Narayan P, Bonner JM, Kory N,	Sci Transl Med	2021	1
APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therape [PMID:33340485]	Serrano-Pozo A, Das S, Hyman BT	Lancet Neurol	2021	1
Astrocytic α7-nicotinic acetylcholine receptors mediate pain information process [PMID:41453579]	Teng T, Yang S, Li J, Wang H, Wu F, He Y	Neurobiology of disease	2026	0
Modulating LRP1 Pathways in Alzheimer's Disease: Mechanistic Insights and Emergi [PMID:41772271]	Mushtaq T, Hameed H, Khan MA, Tariq U, H	Molecular neurobiology	2026	0
Signal-Level Determinants of Cognitive Decline With PPIs versus H2RAs: Transport [PMID:41663888]	Saihati HAA, Ahmed BY, Mosaad RM, El-Gar	Molecular nutrition & food res	2026	0
Alzheimer and cardiovascular genetic scores and cognition: the FINGER randomized [PMID:40747850]	Saadmaan G, Dalmasso MC, Maria M, Lehtis	Brain	2026	0
Postoperative cognitive dysfunction and neurodegeneration: From inflammation to [PMID:41679672]	Lin X, Luo Y, Zhu Q	Brain Res Bull	2026	0
Lipidome and proteome of astrocyte and microglia ApoE lipoprotein reveal differe [PMID:41692246]	Strickland MR, Wang Z, Golden LR, Wang H	J Lipid Res	2026	0
Nicotine Suppresses Human Memory Th Cell Subsets With Preferential Effects on Ce [PMID:41928597]	Gholizadeh F, Hajiaghayi M, Rahbari N, C	Eur J Immunol	2026	0
CRISPR-Cas9 and next-generation gene editing strategies for therapeutic interven [PMID:41931258]	Khan MS, Zafar I, Jamal A, Bahwerth FS,	Acta Neurol Belg	2026	0
Alpha 7 nicotinic acetylcholine receptor contributes to long-term cognitive reco [PMID:41270982]	Nguyen DT, Mendoza K, Hall C, Tan C, Cha	Experimental neurology	2026	0
Alzheimer's disease basics: we all should know. [PMID:40639927]	Das S	Neurological research	2026	0
APOE4 reprograms microglial lipid metabolism in Alzheimer's disease: Mechanisms [PMID:40835432]	["Chen Jiajie", "Zhao Shuoyan", "Zhou Yi	Bioscience trends	2026	0
Putative α7-selective ligands interact with α9-containing nicotinic acetylcholin [PMID:41890755]	Mobasher M, Hone AJ, Pilzecker M, Bozic	Frontiers in immunology	2026	0
Genetic modifiers of APOE-ε4-associated cognitive decline. [PMID:41720779]	Contreras AG, Walters S, Eissman JM, Arc	Nature communications	2026	0
Short-term exposure to a high-fat diet leads to neuroinflammation and impairs me [PMID:41565126]	Costa SO, Silva IM, Chaves WF, Esteves A	The Journal of nutritional bio	2026	0
Protective ApoE variants support neuronal function by effluxing oxidized phospho [PMID:41338186]	Ralhan I, Do AD, Bae JY, Feringa FM, Cai	Neuron	2026	0
Acetylcholine enhances HIF-1α signaling in pancreatic cancer cells under hypoxia [PMID:41608625]	Cho Y, Kim HG, Kang JH, Oh ET, Park HJ	International journal of biolo	2026	0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning CIN in their description or question text

Ganglioside Rebalancing Therapy

Score: 0.690 · neurodegeneration · 2026-04-02

## Mechanistic Overview Ganglioside Rebalancing Therapy starts from the claim that modulating ST3GAL2/ST8SIA1 within the

Astrocyte-Selective APOE4 Silencing via Lipid Nanoparticles

Score: 0.682 · neurodegeneration · 2026-04-04

## Molecular Mechanism and Rationale The apolipoprotein E4 (APOE4) allele represents the strongest genetic risk factor

Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain Anti-Inflammatory Com

Score: 0.669 · neurodegeneration · 2026-04-02

## Mechanistic Overview Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain Anti-Inflammatory Communication start

H6: miR-132/212 Cluster Silencing Disables Neuronal Chromatin Compaction and Sur

Score: 0.660 · neurodegeneration · 2026-04-22

## Mechanistic Overview H6: miR-132/212 Cluster Silencing Disables Neuronal Chromatin Compaction and Survival starts fro

Astrocyte-Microglia Communication Rebalancing via Cytokine Modulation

Score: 0.655 · neurodegeneration · 2026-04-04

## Mechanistic Overview Astrocyte-Microglia Communication Rebalancing via Cytokine Modulation starts from the claim that

mTORC1 displacement from lysosomal surface enables calcineurin access to TFEB

Score: 0.650 · neurodegeneration · 2026-04-21

## Mechanistic Overview mTORC1 displacement from lysosomal surface enables calcineurin access to TFEB starts from the cl

IL-10-Producing B10 Cells Establish AQP4-Specific Peripheral Tolerance Through M

Score: 0.648 · neuroinflammation · 2026-04-13

## Mechanistic Overview IL-10-Producing B10 Cells Establish AQP4-Specific Peripheral Tolerance Through Macrophage Reprog

Epigenetic Silencing of AIF1 Gene Locus by Chronic Inflammation

Score: 0.643 · neuroinflammation · 2026-04-21

## **Molecular Mechanism and Rationale** The epigenetic silencing of the AIF1 (Allograft Inflammatory Factor 1) gene lo

HDAC2 Phospho-Lock Window for Synaptic Gene Silencing

Score: 0.643 · neurodegeneration · 2026-04-21

## Mechanistic Overview HDAC2 Phospho-Lock Window for Synaptic Gene Silencing starts from the claim that modulating HDAC

Glycine-Rich Domain Competitive Inhibition

Score: 0.640 · neurodegeneration · 2026-04-02

## Mechanistic Overview Glycine-Rich Domain Competitive Inhibition starts from the claim that modulating TARDBP within t

HBOT at 1.5 ATA for 60 min induces hormetic response via Nrf2 activation, enhanc

Score: 0.640 · neurodegeneration · 2026-04-25

This hypothesis posits that mild hyperbaric oxidative stress activates Nrf2-ARE transcriptional programs, upregulating S

Butyrate-Producing Commensal Depletion Creates Vicious Cycle: HDAC3 Overactivity

Score: 0.630 · neurodegeneration · 2026-04-26

Butyrate acts as a pan-HDAC inhibitor suppressing microglial HDAC3 activity. In dysbiosis, butyrate deficiency permits H

TREM2 Antagonism in Late-Stage Tauopathy — Reducing Neuroinflammatory Amplificat

Score: 0.628 · Alzheimer's disease · 2026-04-04

## Mechanistic Overview TREM2 Antagonism in Late-Stage Tauopathy — Reducing Neuroinflammatory Amplification starts from

Nuclear TDP-43 Depletion Drives Synaptic Splicing Dysregulation in ALS-FTD

Score: 0.620 · neurodegeneration · 2026-04-22

## Mechanistic Overview Nuclear TDP-43 Depletion Drives Synaptic Splicing Dysregulation in ALS-FTD starts from the claim

Calmodulin isoform switching from CaMK to calcineurin activation upon lysosomal

Score: 0.607 · neurodegeneration · 2026-04-21

## Mechanistic Overview Calmodulin isoform switching from CaMK to calcineurin activation upon lysosomal permeabilization